More importantly, the pre-treatment of OxLDL upregulates virus infection in ECs (Figure 7C), suggesting that the induction of MAGI1 by OxLDL increases EC activation and accelerates virus infection by inhibiting IAV-mediated anti-viral responses (Figure 7E). This evidence concerns the gene MAGI1 and viral infectious disease.